| Drug Name |
Labetalol |
| Drug ID |
BADD_D01236 |
| Description |
Labetalol is a racemic mixture of 2 diastereoisomers where dilevalol, the R,R' stereoisomer, makes up 25% of the mixture.[L7730] Labetalol is formulated as an injection or tablets to treat hypertension.[L7727,L7730]
Labetalol was granted FDA approval on 1 August 1984.[L7724] |
| Indications and Usage |
Labetalol injections are indicated to control blood pressure in severe hypertension.[L7727] Labetalol tablets are indicated alone or in combination with antihypertensives like thiazides and loop diuretics to manage hypertension.[L7730] |
| Marketing Status |
approved |
| ATC Code |
C07AG01 |
| DrugBank ID |
DB00598
|
| KEGG ID |
D08106
|
| MeSH ID |
D007741
|
| PubChem ID |
3869
|
| TTD Drug ID |
D0A8XN
|
| NDC Product Code |
10135-713; 10135-711; 10135-712 |
| UNII |
R5H8897N95
|
| Synonyms |
Labetalol | Labetolol | Albetol | Apo-Labetalol | Apo Labetalol | ApoLabetalol | Trandate | Labetalol Hydrochloride | Hydrochloride, Labetalol | Normodyne | Presolol | SCH-19927 | SCH 19927 | SCH19927 | AH-5158 | AH 5158 | AH5158 | Dilevalol | Labetalol, (R,R)-Isomer | R,R-Labetalol | R,R Labetalol |
